NYSEARCA:FOXO - NYSE Arca - US3514713052 - Common Stock - Currency: USD
0.205
+0 (+0.79%)
The current stock price of FOXO is 0.205 USD. In the past month the price decreased by -23.08%. In the past year, price decreased by -39.65%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
SAP | SAP SE-SPONSORED ADR | 59.83 | 330.11B | ||
CRM | SALESFORCE INC | 31.94 | 296.48B | ||
PLTR | PALANTIR TECHNOLOGIES INC-A | 247.2 | 230.78B | ||
ADBE | ADOBE INC | 24.12 | 193.42B | ||
INTU | INTUIT INC | 33.26 | 158.29B | ||
APP | APPLOVIN CORP-CLASS A | 91.48 | 139.37B | ||
MSTR | MICROSTRATEGY INC-CL A | N/A | 77.37B | ||
TEAM | ATLASSIAN CORP-CL A | 87.19 | 74.93B | ||
SNPS | SYNOPSYS INC | 35.46 | 73.40B | ||
CDNS | CADENCE DESIGN SYS INC | 43.27 | 70.85B | ||
WDAY | WORKDAY INC-CLASS A | 36.89 | 68.20B | ||
ROP | ROPER TECHNOLOGIES INC | 31.33 | 61.56B |
FOXO Technologies, Inc. develops genetic sequencing technology artificial intelligence and bioinformatics tools. The company is headquartered in Minneapolis, Minnesota. The company went IPO on 2020-12-11. The firm owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. The company applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. The company offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
FOXO TECHNOLOGIES INC
729 Washington Ave. N, Suite 600
Minneapolis MINNESOTA US
Employees: 4
Company Website: http://delwinds.com/
Investor Relations: https://foxotechnologies.com/investors/
Phone: 16125629447
The current stock price of FOXO is 0.205 USD. The price increased by 0.79% in the last trading session.
The exchange symbol of FOXO TECHNOLOGIES INC is FOXO and it is listed on the NYSE Arca exchange.
FOXO stock is listed on the NYSE Arca exchange.
FOXO TECHNOLOGIES INC (FOXO) has a market capitalization of 4.83M USD. This makes FOXO a Nano Cap stock.
FOXO TECHNOLOGIES INC (FOXO) currently has 4 employees.
FOXO TECHNOLOGIES INC (FOXO) has a support level at 0.2 and a resistance level at 0.21. Check the full technical report for a detailed analysis of FOXO support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
FOXO does not pay a dividend.
FOXO TECHNOLOGIES INC (FOXO) will report earnings on 2025-06-04.
FOXO TECHNOLOGIES INC (FOXO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.34).
The outstanding short interest for FOXO TECHNOLOGIES INC (FOXO) is 5.94% of its float. Check the ownership tab for more information on the FOXO short interest.
ChartMill assigns a fundamental rating of 1 / 10 to FOXO. FOXO may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months FOXO reported a non-GAAP Earnings per Share(EPS) of -1.34. The EPS increased by 94.84% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -26.81% | ||
ROE | N/A | ||
Debt/Equity | N/A |